Ecovyst Inc. (ECVT) stock
ECVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3053% above fair value
$10.97+0.22 (+2.05%)
Close on Nov 13, 2026Market cap $1.20BP/E 34.3Yield –
Ecovyst r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2024 it was $6.81M, down 12.6% from the year before. The highest annual figure on record is $13.86M in fiscal 2017.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $6.81M | -12.6% |
| FY2023 | Dec 31, 2023 | $7.80M | +7.8% |
| FY2022 | Dec 31, 2022 | $7.23M | -3.6% |
| FY2021 | Dec 31, 2021 | $7.50M | +5.1% |
| FY2020 | Dec 31, 2020 | $7.14M | -3.0% |
| FY2019 | Dec 31, 2019 | $7.36M | -46.4% |
| FY2018 | Dec 31, 2018 | $13.72M | -1.0% |
| FY2017 | Dec 31, 2017 | $13.86M | +90.7% |
| FY2016 | Dec 31, 2016 | $7.27M | – |
| FY2015 | Dec 31, 2015 | $0 | – |
See a number that looks wrong?